• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa.在使用司库奇尤单抗治疗化脓性汗腺炎期间，BNT162b2 mRNA新冠疫苗的安全性和有效性。
Clin Dermatol. 2021 Jul-Aug;39(4):701-702. doi: 10.1016/j.clindermatol.2021.05.026. Epub 2021 May 19.
2
COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.一名接受司库奇尤单抗治疗、患有化脓性汗腺炎和系统性红斑狼疮的患者感染了新冠病毒。
Int J Dermatol. 2020 Nov;59(11):1423-1424. doi: 10.1111/ijd.15209. Epub 2020 Sep 23.
3
No impact of immunomodulatory treatments on SARS-CoV-2 (COVID-19) vaccine outcomes: A cross-sectional analysis of biologic and small molecule inhibitors used for psoriasis and hidradenitis suppurativa patients from the Epic Cosmos database.免疫调节治疗对SARS-CoV-2（新冠病毒病）疫苗效果无影响：对Epic Cosmos数据库中用于银屑病和化脓性汗腺炎患者的生物制剂和小分子抑制剂的横断面分析
J Am Acad Dermatol. 2024 Jul;91(1):100-102. doi: 10.1016/j.jaad.2024.03.004. Epub 2024 Mar 13.
4
Anti-COVID-19 measurements for hidradenitis suppurativa patients.防治化脓性汗腺炎患者感染 COVID-19 的措施。
Exp Dermatol. 2021 Jun;30 Suppl 1(Suppl 1):18-22. doi: 10.1111/exd.14339.
5
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: 'Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa'.化脓性汗腺炎患者在新冠疫苗接种期间的管理：来自意大利南部的经验。评论：“评估化脓性汗腺炎患者接种新冠疫苗的安全性和有效性”
Clin Exp Dermatol. 2022 Nov;47(11):2026-2028. doi: 10.1111/ced.15306. Epub 2022 Aug 4.
6
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.新冠疫情期间化脓性汗腺炎患者的管理
Dermatol Ther. 2020 Nov;33(6):e13875. doi: 10.1111/dth.13875. Epub 2020 Jul 7.
7
Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa.司库奇尤单抗：治疗银屑病和化脓性汗腺炎的有效药物。
Dermatol Ther. 2020 Jul;33(4):e13756. doi: 10.1111/dth.13756. Epub 2020 Jun 29.
8
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa.阿达木单抗诱发的矛盾性脓疱型银屑病和脱发在一名患有化脓性汗腺炎的患者中用司库奇尤单抗成功治疗。
J Dermatolog Treat. 2023 Dec;34(1):2256905. doi: 10.1080/09546634.2023.2256905.
9
Ixekizumab in hidradenitis suppurativa in a psoriatic patient.司库奇尤单抗治疗一名银屑病患者的化脓性汗腺炎
G Ital Dermatol Venereol. 2020 Dec;155(6):788-789. doi: 10.23736/S0392-0488.18.06135-7. Epub 2019 Jan 9.
10
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?在新冠疫情期间，化脓性汗腺炎的生物治疗与银屑病的生物治疗有何不同？
J Dermatolog Treat. 2022 Feb;33(1):599. doi: 10.1080/09546634.2020.1771256. Epub 2020 Jun 19.

引用本文的文献

1
Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa Part I: Topical and Systemic Medical Therapies.化脓性汗腺炎的新兴治疗方法及临床试验概况 第一部分：局部和全身药物治疗
Dermatol Ther (Heidelb). 2023 Aug;13(8):1661-1697. doi: 10.1007/s13555-023-00956-6. Epub 2023 Jul 4.
2
Validation of an HPLC-CAD Method for Determination of Lipid Content in LNP-Encapsulated COVID-19 mRNA Vaccines.用于测定脂质纳米颗粒包裹的新冠病毒 mRNA 疫苗中脂质含量的高效液相色谱 - 蒸发光散射检测法的验证
Vaccines (Basel). 2023 May 4;11(5):937. doi: 10.3390/vaccines11050937.
3
Acute Hepatitis of Unknown Origin (AHUO)-The Puzzle Ahead.不明原因急性肝炎（AHUO）——前方的谜题。
Diagnostics (Basel). 2022 May 12;12(5):1215. doi: 10.3390/diagnostics12051215.
4
Development of COVID 19 vaccine: A summarized review on global trials, efficacy, and effectiveness on variants.COVID-19 疫苗的研发：全球试验、对变异株的疗效和效果的综述评价。
Diabetes Metab Syndr. 2022 Apr;16(4):102482. doi: 10.1016/j.dsx.2022.102482. Epub 2022 Apr 8.

本文引用的文献

1
Systemic antibiotics in hidradenitis suppurativa: efficacy and effects of body mass index and smoking pack-year on the response to therapy.化脓性汗腺炎的全身性抗生素治疗：疗效以及体重指数和吸烟包年数对治疗反应的影响。
Dermatol Ther. 2021 May;34(3):e14919. doi: 10.1111/dth.14919. Epub 2021 Mar 7.
2
COVID-19 vaccines: where we stand and challenges ahead.COVID-19 疫苗：我们的现状和未来的挑战。
Cell Death Differ. 2021 Feb;28(2):626-639. doi: 10.1038/s41418-020-00720-9. Epub 2021 Jan 21.
3
COVID-19 Vaccine and Biologics: An Impending Dilemma.COVID-19 疫苗和生物制剂：迫在眉睫的困境。
J Drugs Dermatol. 2021 Jan 1;20(1):115-114. doi: 10.36849/JDD.5628.
4
Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis suppurativa, and acne/rosacea during the COVID-19 pandemic.2019冠状病毒病大流行期间银屑病、特应性皮炎（湿疹）、化脓性汗腺炎及痤疮/玫瑰痤疮治疗指南的更新
Dermatol Online J. 2020 Oct 15;26(10):13030/qt0j5150df.
5
Immunological mechanisms of vaccination.疫苗接种的免疫学机制。
Nat Immunol. 2011 Jun;12(6):509-17. doi: 10.1038/ni.2039.

Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine during Ixekizumab treatment for hidradenitis suppurativa.

作者信息

Iannone Michela, Janowska Agata, Tonini Giulia, Davini Giulia, Dini Valentina

机构信息

Department of Dermatology, University of Pisa, Pisa, Italy.

Department of Dermatology, University of Pisa, Pisa, Italy.

出版信息

Clin Dermatol. 2021 Jul-Aug;39(4):701-702. doi: 10.1016/j.clindermatol.2021.05.026. Epub 2021 May 19.

DOI:10.1016/j.clindermatol.2021.05.026
PMID:34809775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8131181/
Abstract
摘要